Comparing hospital admissions, comorbidities, and biomarkers between severe asthma and Gold III-IV chronic obstructive pulmonary disease.
Eduardo Vieira PonteCintia B MingottiCarolina Souza-MachadoJuçara N SilvaLucas ChequiFlávio F ArbexAlcides RochaAlvaro A CruzPublished in: The clinical respiratory journal (2021)
Our results demonstrated that Gold III-IV COPD subjects had worse outcomes as compared with SA subjects. We also observed that the frequency of atopy and high peripheral blood eosinophil count were similar between study groups. Finally, we exposed aspects of comorbidities related to asthma and COPD that indicate the need of close monitoring the cardiovascular risk in SA subjects above 40 years of age.